Do we trust the government? Attributes of COVID-19 vaccine hesitancy and acceptance in Nigeria

Osmond C. Ekwebelem; Helen Onyeaka; Ismaeel Yunusa; Taghi Miri; Yahwedalu M. Onwuneme; Ayeni T. Eunice; Amara Anyogu; Bright Obi; Ngwogu Ada Carol; Osmond C. Ekwebelem; Helen Onyeaka; Ismaeel Yunusa; Taghi Miri; Yahwedalu M. Onwuneme; Ayeni T. Eunice; Amara Anyogu; Bright Obi; Ngwogu Ada Carol

doi:10.3934/medsci.2022010

AIMS Medical Science

2022, Volume 9, Issue 2: 268-282. doi: 10.3934/medsci.2022010

Previous Article Next Article

Research article

Do we trust the government? Attributes of COVID-19 vaccine hesitancy and acceptance in Nigeria

1.
Faculty of Biological Sciences, University of Nigeria, Nsukka, Nigeria
2.
School of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham, UK
3.
Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, South Carolina, USA
4.
Faculty of Biosciences, Nnamdi Azikiwe University, Akwa, Nigeria
5.
Department of Regulatory Affairs, Fensyl MHP Consulting Group, Lagos, Nigeria
6.
School of Life Sciences, University of Westminster, UK
7.
Department of Medical Microbiology, Abia State University Teaching Hospital, Aba, Nigeria

Received: 01 February 2022 Revised: 31 March 2022 Accepted: 07 April 2022 Published: 15 April 2022

Objectives
A significant percentage of the population must be vaccinated to achieve herd immunity. Therefore the success of a vaccination program relies on the level of acceptance. This present study seeks to understand COVID-19 vaccine acceptance and hesitancy in Nigeria by assessing the public's willingness to get vaccinated.
Study design
This is a population-based cross-sectional study. Data were derived through a structured online survey.
Methods
A cross-sectional study was conducted among adult residents in Nigeria in March 2021 using a structured online questionnaire. The questionnaire surveyed participants' demographic characteristics and perception of COVID-19 and the COVID-19 vaccine. Descriptive statistics and inferential statistics using Chi-square, as well as univariable logistic regression to determine the factors associated with acceptance of COVID-19 vaccine was conducted.
Results
Of the 618 respondents, 272 (44%) reported being willing to get vaccinated. Interestingly, of the 346 (56%) respondents that would not take the COVID-19 vaccine, the highest marginal reasons for non-acceptance were lack of trust in the government 163 (47.1%), followed by the belief that the vaccine is not safe 67 (19.4%), and no enough information about the vaccine 49 (13.6%). In addition, male respondents and those with a university degree or above were statistically significantly more likely to accept a COVID-19 vaccine.
Conclusion
A considerable proportion of the study population is unwilling to receive a COVID-19 vaccine. This observation highlights the need for the government, public health officials, and advocacy groups to implement immediate awareness-raising measures to sway the public towards COVID-19 vaccine acceptance.
- vaccine acceptance,
- vaccine hesitancy,
- COVID-19,
- Nigeria,
- vaccine coverage
Citation: Osmond C. Ekwebelem, Helen Onyeaka, Ismaeel Yunusa, Taghi Miri, Yahwedalu M. Onwuneme, Ayeni T. Eunice, Amara Anyogu, Bright Obi, Ngwogu Ada Carol. Do we trust the government? Attributes of COVID-19 vaccine hesitancy and acceptance in Nigeria[J]. AIMS Medical Science, 2022, 9(2): 268-282. doi: 10.3934/medsci.2022010

Related Papers:

Abstract

Objectives

A significant percentage of the population must be vaccinated to achieve herd immunity. Therefore the success of a vaccination program relies on the level of acceptance. This present study seeks to understand COVID-19 vaccine acceptance and hesitancy in Nigeria by assessing the public's willingness to get vaccinated.

Study design

This is a population-based cross-sectional study. Data were derived through a structured online survey.

Methods

A cross-sectional study was conducted among adult residents in Nigeria in March 2021 using a structured online questionnaire. The questionnaire surveyed participants' demographic characteristics and perception of COVID-19 and the COVID-19 vaccine. Descriptive statistics and inferential statistics using Chi-square, as well as univariable logistic regression to determine the factors associated with acceptance of COVID-19 vaccine was conducted.

Results

Of the 618 respondents, 272 (44%) reported being willing to get vaccinated. Interestingly, of the 346 (56%) respondents that would not take the COVID-19 vaccine, the highest marginal reasons for non-acceptance were lack of trust in the government 163 (47.1%), followed by the belief that the vaccine is not safe 67 (19.4%), and no enough information about the vaccine 49 (13.6%). In addition, male respondents and those with a university degree or above were statistically significantly more likely to accept a COVID-19 vaccine.

Conclusion

A considerable proportion of the study population is unwilling to receive a COVID-19 vaccine. This observation highlights the need for the government, public health officials, and advocacy groups to implement immediate awareness-raising measures to sway the public towards COVID-19 vaccine acceptance.

Author contributions

Conceptualization: OCE, HO. Data curation: OCE. Formal analysis: OCE, HO, IY. Methodology: OCE, HO. Project administration: OCE, HO. Visualization: IY, YMO, ATE, BO. Writing—original draft: OCE, HO. Writing—review & editing: IY, YMO, ATE, BO, TM, AA and NAC.

Funding

No funding was received for research.

Conflicts of interests

The authors have no competing interests to declare.

References

[1]	World Health Organization (WHO)COVID-19 vaccine tracker and landscape (2020). Available from: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
[2]	Apolone G, Montomoli E, Manenti A, et al. (2021) Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy. Tumori J 107: 446-451. https://doi.org/10.1177/0300891620974755
[3]	La Rosa G, Mancini P, Ferraro GB, et al. (2021) SARS-CoV-2 has been circulating in northern Italy since December 2019: evidence from environmental monitoring. Sci Total Environ 750: 141711. https://doi.org/10.1016/j.scitotenv.2020.141711
[4]	Al-Sharify ZT, Nussrat HH, Al-Najjar SZ, et al. (2021) The emergence of COVID-19 and its pandemic potentialas a global health security threat and its effect on future life strategy. System Rev Pharm 12: 259-269.
[5]	Ekwebelem OC, Ofielu ES, Nnorom-Dike OV, et al. (2021) Threats of COVID-19 to achieving united nations sustainable development goals in Africa. Am J Trop Med Hyg 104: 457-460. https://doi.org/10.4269/ajtmh.20-1489
[6]	Lazarus JV, Ratzan SC, Palayew A, et al. (2021) A global survey of potential acceptance of a COVID-19 vaccine. Nat Med 27: 225-228. https://doi.org/10.1038/s41591-020-1124-9
[7]	Yunusa I, Iloanusi S, Mgbere O, et al. (2021) Public opinion regarding government response to COVID-19: case study of a large commercial city in Nigeria. Pan Afr Med J 38: 282. https://doi.org/10.11604/pamj.2021.38.282.26361
[8]	Ekwebelem OC, Yunusa I, Onyeaka H, et al. (2021) COVID-19 vaccine rollout: will it affect the rates of vaccine hesitancy in Africa?. Public Health 197: e18-e19. https://doi.org/10.1016/j.puhe.2021.01.010
[9]	Adepoju P (2020) Nigeria responds to COVID-19; first case detected in sub-Saharan Africa. Nat Med 26: 444-448. https://doi.org/10.1038/d41591-020-00004-2
[10]	Kalu B (2020) COVID-19 in Nigeria: a disease of hunger. Lancet Respir Med 8: 556-557. https://doi.org/10.1016/S2213-2600(20)30220-4
[11]	Nigeria Center for Disease Control (NCDC)COVID-19 outbreak in Nigeria situation report (2020). Available from: https://ncdc.gov.ng/themes/common/files/%20annualreports/18803aba62a09ada4ad84c8db76c22ea.pdf
[12]	Africa CDCCoronavirus Disease 2019 (COVID-19) latest updates on the COVID-19 crisis from Africa CDC (2021). Available from: https://africacdc.org/covid-19/
[13]	World Health Organization (WHO)Strategic Advisory Group of Experts on Immunisation. Report of the SAGE working group on vaccine hesitancy. [cited 14th March 2022] (2021). Available from: https://www.medbox.org/document/report-of-the-sage-working-group-on-vaccine-hesitancy#GO
[14]	Lozano R, Naghavi M, Foreman K, et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095-2128. https://doi.org/10.1016/S0140-6736(12)61728-0
[15]	Aborode AT, Fajemisin EA, Ekwebelem OC, et al. (2021) Vaccine hesitancy in Africa: causes and strategies to the rescue. Ther Adv Vaccines Immunother 9: 25151355211047514. https://doi.org/10.1177/25151355211047514
[16]	Onyeaka H, Al-Sharify ZT, Ghadhban MY, et al. (2021) A review on the advancements in the development of vaccines to combat coronavirus disease 2019. Clin Exp Vaccine Res 10: 6-12. https://doi.org/10.7774/cevr.2021.10.1.6
[17]	Adebisi YA, Prisno DEL, Nuga BB (2020) Last fight of wild polio in Africa: Nigeria's battle. Public Health Pract 1: 100043. https://doi.org/10.1016/j.puhip.2020.100043
[18]	Ekwebelem OC, Nnorom-Dike OV, Aborode AT, et al. (2021) Eradication of wild poliovirus in Nigeria: lessons learnt. Public Health Pract 2: 100144. https://doi.org/10.1016/j.puhip.2021.100144
[19]	Malik AA, McFadden SM, Elharake J, et al. (2020) Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine 26: 100495. https://doi.org/10.1016/j.eclinm.2020.100495
[20]	Adebisi YA, Alaran AJ, Bolarinwa OA, et al. (2021) When it is available, will we take it? Social media users' perception of hypothetical COVID-19 vaccine in Nigeria. Pan Afr Med J 38: 230. https://doi.org/10.11604/pamj.2021.38.230.27325
[21]	Larson HJ, Clarke RM, Jarrett C, et al. (2018) Measuring trust in vaccination: A systematic review. Hum Vaccin Immunother 14: 1599-1609. https://doi.org/10.1080/21645515.2018.1459252
[22]	Flaxman S, Mishra S, Gandy A, et al. (2020) Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature 584: 257-261. https://doi.org/10.1038/s41586-020-2405-7
[23]	Sanche S, Lin YT, Xu C, et al. (2020) High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis 26: 1470-1477. https://doi.org/10.3201/eid2607.200282
[24]	IPSOSThree in four adults globally say they would get a vaccine for COVID-19. [14th March 2022] (2020). Available from: https://www.ipsos.com/en/three-four-adults-globally-say-theyd-get-vaccine-covid-19
[25]	Neumann-Böhme S, Varghese NE, Sabat I, et al. (2020) Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ 21: 977-982. https://doi.org/10.1007/s10198-020-01208-6
[26]	Harapan H, Wagner AL, Yufika A, et al. (2020) Acceptance of a COVID-19 vaccine in Southeast Asia: A cross-sectional study in Indonesia. Front Public Health 8: 381. https://doi.org/10.3389/fpubh.2020.00381
[27]	Wong LP, Alias H, Wong PF, et al. (2020) The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccin Immunother 16: 2204-2214. https://doi.org/10.1080/21645515.2020.1790279
[28]	Nzaji MK, Ngombe LK, Mwamba GN, et al. (2020) Acceptability of vaccination against COVID-19 among healthcare workers in the Democratic Republic of the Congo. Pragmat Obs Res 11: 103-109. https://doi.org/10.2147/POR.S271096
[29]	Thorneloe R, Wilcockson H, Lamb M, et al. (2020) Willingness to receive a COVID-19 vaccine among adults at high-risk of COVID-19: a UK-wide survey. PsyArXiv Preprints . https://doi.org/10.31234/osf.io/fs9wk
[30]	Dodd RH, Cvejic E, Bonner C, et al. (2021) Willingness to vaccinate against COVID-19 in Australia. Lancet Infect Dis 21: 318-319. https://doi.org/10.1016/S1473-3099(20)30559-4
[31]	Kourlaba G, Kourkouni E, Maistreli S, et al. (2021) Willingness of Greek general population to get a COVID-19 vaccine. Glob Health Res Policy 6: 1-10. https://doi.org/10.1186/s41256-021-00188-1
[32]	European Centre for Disease Prevention and Control (ECDC)Catalogue of interventions addressing vaccine hesitancy (2017). Available from: https://www.ecdc.europa.eu/sites/default/files/documents/Catalogue-interventions-vaccine-hesitancy.pdf
[33]	Thomson A, Vallee-Tourangeau G, Suggs LS (2018) Strategies to increase vaccine acceptance and uptake: From behavioral insights to context-specific, culturally-appropriate, evidence-based communications and interventions. Vaccine 36: 6457-6458. https://doi.org/10.1016/j.vaccine.2018.08.031
[34]	Betsch C, Schmid P, Heinemeier D, et al. (2018) Beyond confidence: development of a measure assessing the 5C psychological antecedents of vaccination. PloS One 13: e0208601. https://doi.org/10.1371/journal.pone.0208601
[35]	Siegrist M, Zingg A (2014) The role of public trust during pandemics: implications for crisis communication. Eur Psychol 19: 23-32. https://doi.org/10.1027/1016-9040/a000169
[36]	Eysenbach G (2004) Improving the quality of web surveys: the checklist for reporting results of internet e-surveys (CHERRIES). J Med Internet Res 6: e34. https://doi.org/10.2196/jmir.6.3.e34
[37]	Wyatt J (2000) When to use web-based surveys. J Am Med Inform Assoc 7: 426-429. https://doi.org/10.1136/jamia.2000.0070426

Reader Comments

Your name:*

Email:*
© 2022 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)